Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 8Active not recruiting 3Unknown 2Terminated 1Recruiting 1

Sponsor Class

OTHER 61INDUSTRY 8OTHER_GOV 6UNKNOWN 3NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Pancreatic Neoplasms 2

Interventions

Cisplatin 15Paclitaxel 14Taxes 10Cyclophosphamide 9Carboplatin 9Gemcitabine 7Platinum 61,2-diaminocyclohexaneplatinum II citrate 6Trastuzumab 5Radiotherapy 5Oxaliplatin 5Doxorubicin 5Docetaxel 5Cytarabine 5Capecitabine 5Brachytherapy 5fludarabine 4Rituximab 4Radiotherapy, Intensity-Modulated 4Radiosurgery 4Fluorouracil 4Dexamethasone 4Watchful Waiting 3Radiotherapy, Conformal 3Pemetrexed 3Nimorazole 3Lenalidomide 3Imatinib Mesylate 3Idarubicin 3Gene Expression Profiling 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × NETWORK × Albumin-Bound Paclitaxel × Clear all
NCT05042128 2024-10-22

ASCEND

Australasian Gastro-Intestinal Trials Group

Phase 2 Unknown
158 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT04089150 2021-10-22

MASTERPLAN

Australasian Gastro-Intestinal Trials Group

Phase 2 Unknown
120 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡